News
BLRX
1.580
-7.60%
-0.130
Weekly Report: what happened at BLRX last week (1102-1106)?
Weekly Report · 11h ago
Weekly Report: what happened at BLRX last week (1026-1030)?
Weekly Report · 11/02 09:46
Weekly Report: what happened at BLRX last week (1019-1023)?
Weekly Report · 10/26 09:46
Analysts Offer Insights on Healthcare Companies: Zentalis Pharmaceuticals (ZNTL), Bioline RX Ltd Sponsored ADR (BLRX) and Evaxion Biotech (EVAX)
TipRanks · 10/23 17:30
BioLineRx and Hemispherian Report GLIX1–PARP Inhibitor Synergy in HR-Proficient Ovarian Cancer
TipRanks · 10/23 11:27
BioLineRx And Hemispherian Present Data At ESMO 2026 Demonstrating Synergy Between GLIX1 And Multiple PARPi In Homologous Recombination-Proficient Ovarian Cancer Cell Lines And In In Vivo Patient-Derived Xenograft Model
Benzinga · 10/23 11:05
Weekly Report: what happened at BLRX last week (1012-1016)?
Weekly Report · 10/19 09:46
Weekly Report: what happened at BLRX last week (1005-1009)?
Weekly Report · 10/12 09:49
BioLineRx Announces That Two Abstracts Featuring GLIX1 Will Be Presented At The Society For Neuro-Oncology Annual Meeting, November 12-15
Benzinga · 10/08 11:05
BioLineRx and Hemispherian Announce Two GLIX1 Presentations at the 31st Society for Neuro-Oncology (SNO) Annual Meeting & Education Day
PR Newswire · 10/08 11:00
Weekly Report: what happened at BLRX last week (0928-1002)?
Weekly Report · 10/05 09:48
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 09/30 21:05
Weekly Report: what happened at BLRX last week (0921-0925)?
Weekly Report · 09/28 09:46
BioLineRx files to sell 2.02M American Depositary Shares for holders
TipRanks · 09/25 20:35
BioLineRx Shareholders Approve Board, Capital and Compensation Moves at 2026 AGM
TipRanks · 09/24 20:27
Weekly Report: what happened at BLRX last week (0914-0918)?
Weekly Report · 09/21 09:46
Weekly Report: what happened at BLRX last week (0907-0911)?
Weekly Report · 09/14 09:49
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 09/10 12:06
BioLineRx And Hemispherian To Present GLIX1 Data At EANO 2026; Stock Up
NASDAQ · 09/10 12:01
BioLineRx and Hemispherian to Showcase GLIX1 Glioblastoma Data and Trial Design at EANO 2026
TipRanks · 09/10 11:28
More
Webull provides a variety of real-time BLRX stock news. You can receive the latest news about Biolinerx through multiple platforms. This information may help you make smarter investment decisions.
About BLRX
BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.